Virtual Group Resilient Living Program For Patients Living With Advanced Cancer
ConditionAdvanced Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Living Program (RLP) on anxiety, stress, quality of life (QOL), coping, and fatigue among patients with advanced cancer. The group RLP is a psychosocial intervention that consists of a total of 7 weekly sessions in which the interventionalist teaches the patients techniques on stress management and building resilience (mindfulness, uplifting emotions, reframe experiences through principles of gratitude, compassion, acceptance, meaning, and forgiveness). The group setting allows for support and connection amongst the patients, providing further support and motivation to practice the principles of the program.
Eligibility criteria
Qualifiers
English fluency
Diagnosis of advanced (stage III/IV) malignancy
Baseline distress score ≥ 4/10. Patients can answer questions orally rather than complete worksheet, if applicable
Life expectancy of ≥ 6 months
Disqualifiers
As determined through self-report, those diagnosed with a history of a psychotic episode ≤ 5 years
All psychological co-morbidities such as a history of untreated schizophrenia, & bipolar disease
A diagnosis of severe cognitive impairment
Trial design
Treatments tested in this trial
- Virtual Group Resilient Living Program (RLP)
- Survey Completion
Treatment groups
42 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov